
Genevieve S. Alley
Examiner (ID: 12775, Phone: (571)270-1111 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 854 |
| Issued Applications | 465 |
| Pending Applications | 114 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17080434
[patent_doc_number] => 20210275440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => MICROBEAD COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT
[patent_app_type] => utility
[patent_app_number] => 16/334542
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334542
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334542 | MICROBEAD COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT | Sep 26, 2017 | Pending |
Array
(
[id] => 12125046
[patent_doc_number] => 20180008632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'Treatment for Chitin-Containing Microorganisms'
[patent_app_type] => utility
[patent_app_number] => 15/714144
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12048
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15714144
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/714144 | Treatment for Chitin-Containing Microorganisms | Sep 24, 2017 | Abandoned |
Array
(
[id] => 12238342
[patent_doc_number] => 20180071205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'Stable Vitamin C System'
[patent_app_type] => utility
[patent_app_number] => 15/713363
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11898
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15713363
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/713363 | Stable Vitamin C System | Sep 21, 2017 | Abandoned |
Array
(
[id] => 14069523
[patent_doc_number] => 20190083649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => CROSSLINKED POLYMER NANO-ASSEMBLIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/709678
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709678
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709678 | CROSSLINKED POLYMER NANO-ASSEMBLIES AND USES THEREOF | Sep 19, 2017 | Abandoned |
Array
(
[id] => 12183934
[patent_doc_number] => 20180042870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES'
[patent_app_type] => utility
[patent_app_number] => 15/699745
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15661
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699745 | USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES | Sep 7, 2017 | Abandoned |
Array
(
[id] => 12238413
[patent_doc_number] => 20180071277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER'
[patent_app_type] => utility
[patent_app_number] => 15/662175
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17179
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15662175
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/662175 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER | Jul 26, 2017 | Abandoned |
Array
(
[id] => 14372541
[patent_doc_number] => 20190160183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => COMPOSITIONS COMPRISING A POLYSACCHARIDE MATRIX FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 16/318227
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318227
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318227 | COMPOSITIONS COMPRISING A POLYSACCHARIDE MATRIX FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS | Jul 17, 2017 | Abandoned |
Array
(
[id] => 14085567
[patent_doc_number] => 10238663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-26
[patent_title] => Extended-release drug delivery compositions
[patent_app_type] => utility
[patent_app_number] => 15/643857
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7327
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643857
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643857 | Extended-release drug delivery compositions | Jul 6, 2017 | Issued |
Array
(
[id] => 11992359
[patent_doc_number] => 20170296514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'FORMULATIONS OF DEFERASIROX AND METHODS OF MAKING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/636174
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20110
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15636174
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/636174 | Formulations of deferasirox and methods of making the same | Jun 27, 2017 | Issued |
Array
(
[id] => 12157185
[patent_doc_number] => 20180028449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'Technology for the Preparation of Microparticles'
[patent_app_type] => utility
[patent_app_number] => 15/635169
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60842
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15635169
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/635169 | Technology for the Preparation of Microparticles | Jun 26, 2017 | Abandoned |
Array
(
[id] => 14375105
[patent_doc_number] => 20190161465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => Red colorant composition derived from iridoid compounds and method for producing same
[patent_app_type] => utility
[patent_app_number] => 16/309837
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309837 | Red colorant composition derived from iridoid compounds and method for producing same | Jun 15, 2017 | Abandoned |
Array
(
[id] => 12000191
[patent_doc_number] => 20170304346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'USE OF NADH OR SALT THEREOF IN PREPARATION OF DRUGS OR HEALTH-CARE PRODUCTS FOR TREATING PHENYLKETONURIA'
[patent_app_type] => utility
[patent_app_number] => 15/618934
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2104
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618934
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618934 | Use of NADH or salt thereof in preparation of drugs or health-care products for treating phenylketonuria | Jun 8, 2017 | Issued |
Array
(
[id] => 16341582
[patent_doc_number] => 20200306232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => METHODS OF TREATING BONE LOSS
[patent_app_type] => utility
[patent_app_number] => 16/308672
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308672
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308672 | Methods of treating bone loss | Jun 7, 2017 | Issued |
Array
(
[id] => 11963793
[patent_doc_number] => 20170267946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'SURFACTANTS BASED ON MONOUNSATURATED FATTY ALCOHOL DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/606285
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10333
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606285
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606285 | Surfactants based on monounsaturated fatty alcohol derivatives | May 25, 2017 | Issued |
Array
(
[id] => 12054135
[patent_doc_number] => 20170330480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'PREVENTION OF THE WRINKLING AND EXPRESSION OF HUMAN SKIN'
[patent_app_type] => utility
[patent_app_number] => 15/594007
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8045
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15594007
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/594007 | PREVENTION OF THE WRINKLING AND EXPRESSION OF HUMAN SKIN | May 11, 2017 | Abandoned |
Array
(
[id] => 12424959
[patent_doc_number] => 09974824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Low-burst polymers and methods to produce polymer
[patent_app_type] => utility
[patent_app_number] => 15/490615
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 10984
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/490615 | Low-burst polymers and methods to produce polymer | Apr 17, 2017 | Issued |
Array
(
[id] => 13263215
[patent_doc_number] => 10143677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-04
[patent_title] => Taxane analogs for the treatment of brain cancer
[patent_app_type] => utility
[patent_app_number] => 15/483551
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 18785
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483551
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/483551 | Taxane analogs for the treatment of brain cancer | Apr 9, 2017 | Issued |
Array
(
[id] => 13263215
[patent_doc_number] => 10143677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-04
[patent_title] => Taxane analogs for the treatment of brain cancer
[patent_app_type] => utility
[patent_app_number] => 15/483551
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 18785
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483551
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/483551 | Taxane analogs for the treatment of brain cancer | Apr 9, 2017 | Issued |
Array
(
[id] => 18012057
[patent_doc_number] => 11504331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Process for mesalazine solid formulations
[patent_app_type] => utility
[patent_app_number] => 16/091397
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3266
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091397 | Process for mesalazine solid formulations | Apr 3, 2017 | Issued |
Array
(
[id] => 15419695
[patent_doc_number] => 10542746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Lecithin-based spray adjuvant containing organosilicon wetting agents
[patent_app_type] => utility
[patent_app_number] => 15/468350
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7860
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468350 | Lecithin-based spray adjuvant containing organosilicon wetting agents | Mar 23, 2017 | Issued |